Medicaid programs willing to boot out drug pricing middlemen
Axios
— By Bob Herman, October 8, 2019
Michigan’s Medicaid program is proposing to fire the pharmacy benefit managers that handle its prescription drug claims and negotiate prices. The state would manage drug coverage itself, starting Dec. 1.
The big picture: More state Medicaid agencies have determined that outsourcing all negotiations and operations of prescription drugs to PBMs has not produced the dramatic savings they were promised.
Details: Michigan officials said in a bulletin the state could extract bigger rebates from pharmaceutical companies and cut administrative costs if the state handled all Medicaid medication benefits, instead of the current private contractors.
- Michigan would use Magellan as its sole drug claims processor.
- A spokesperson for the Michigan Department of Health and Human Services said the proposal would save $40 million, and officials “will be reviewing the feedback carefully to determine next steps.”
- CVS Health, OptumRx, MedImpact and a handful of other PBMs stand to lose business.
Between the lines: State governments, along with pharmacists, continue to lead the crusades against PBMs.
- A recently signed California regulation will shift all Medicaid drug benefits away from PBMs by 2021, and West Virginia’s Medicaid department fired its PBMs in 2017.
Recent Posts
-
SCPC Congratulates RFK Jr. on Being Confirmed as Secretary of Health and Human Services
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released the following statement today to congratulate Robert F. Kennedy Jr. for being confirmed as Secretary of the U.S. Department of Health and Human Services (HHS).
-
SCPC Calls for Immediate Congressional Action to Fix Broken LTC Pharmacy Payment Model as More Drugs Become Subject to Mandatory Medicare Price Negotiations
SCPC, the leading voice for the nation’s long-term care (LTC) pharmacy community, commends the FTC for once again shining a light on the abusive practices of the big PBMs that continue to rake in massive profits while patients, pharmacies, employers and taxpayers foot the bill for ever-increasing drug prices.
-
SCPC Praises FTC for Report Highlighting Egregious PBM Abuses; Encourages Congress and New Administration to Make PBM Reform an Immediate Priority in 2025
SCPC, the leading voice for the nation’s long-term care (LTC) pharmacy community, commends the FTC for once again shining a light on the abusive practices of the big PBMs that continue to rake in massive profits while patients, pharmacies, employers and taxpayers foot the bill for ever-increasing drug prices.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.